Featured
FDA awards full approval to Paxlovid amidst hazy coverage plans
After earning multimillion dollar revenues while being an authorised preferred treatment for Covid-19, the US Food and Drug Administration (FDA)…
Immuno-oncology market set to grow in billions, but access concerns remain
The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in…
Touchlight boosts DNA manufacturing capacity with latest expansion
Enzymatic DNA production company Touchlight have augmented its DNA production capabilities with a newly announced expansion to its London facilities.…
Beta Bionics’ automated insulin delivery system picks up manufacturing partner
Chronic disease tech company Convatec Group has partnered with Beta Bionics to manufacture the insulin delivery system iLet Bionic Pancrease.…
Illegal online pharmacies gain traction as regulators lag behind
Amidst an insulin pricing crisis and consistent shortages of drugs ranging from Teva’s attention deficit hyperactivity disorder (ADHD) medication Adderall…
UK agency pilots biobank to study links between genetics and drug side effects
The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data…
Transgene and BioInvent report positive data for oncolytic virus
BioInvent International and Transgene’s partnership is looking optimistic following positive Phase 1a data on its oncolytic virus BT-001 for the…
Meningitis vaccine comes to the forefront with impressive study results
A new vaccine developed by the Serum Institute of India to fight meningococcal disease could help eliminate meningitis across Africa.…
FDA delays Sarepta’s DMD gene therapy decision until June
Pushing back an initial deadline, the US Food and Drug Administration (FDA) has proposed a new regulatory action date of…
US government plans proposal to push down Medicaid drug prices
The US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have announced…